Abstract:Objective: To investigate the effect of intrathecal δ-opioid receptor antagonists specificity on morphine tolerance in rats with chronic pain,and to explore possible mechanism of morphine tolerance.Methods: Sprague-Dawley rats were successfully modeled with bone cancer pain or spared nerve injury(SNI),and then intrathecal catheters were placed in.The animals were randomly divided into eight groups: bone cancer pain +saline group(group BC),bone cancer pain +morphine group(group BM),bone cancer pain +naltrindole +morphine group(group BN),bone cancer pain +DPDPE +morphine group(group BD),SNI +saline group(group SC),SNI +morphine group(group SM),SNI +naltrindole +morphine group(group SN),SNI +DPDPE +morphine group(group SD).Rats in each group began to give medicine ten days after pain models were made.Group BC/SC and group BM/SM rats were accepted intrathecal injection(I.T.) of saline and 10 μg morphine which dissolved in 10 μl saline,respectively.In group BN/SN,intrathecal morphine 10 μg/10 μl was given 20 minutes after intrathecal naltrindole 10 μg/10 μl was administered,while rats in group BD/SD were accepted intrathecal DPDPE 1 μg/10 μl at first,and then intrathecal morphine 10 μg/10 μl was injected 20 minutes later.All SNI model rats were injected twice a day for 9 consecutive days,while bone cancer model rats were injected three times a day for 9 consecutive days.The mechanical allodynia was measured respectively at baseline and 3,5,7,9 days(T3,T5,T7,T9) after SNI or bone cancer pain model operation and 1,4,7,9 days(I1,I4,I7,I9) during injection of drugs.Heart perfusion by 4% paraformaldehyde was performed in the implantation rats after the last injection of drugs.Then bilateral tibias of rats were sliced into frozen sections and stained with H-E.Results: H-E stain showed that cells of the implantation tibia had absolutely pleomorphism and the bone defects were extensive.The bone cancer pain model was successful.All animals successfully developed nociceptive hypersensitivity after cancer cell inoculations or SNI operations,and the paw withdrawal threshold significantly reduced(P < 0.05).The paw withdrawal threshold of each group except group BC/SC had a significant increase and revealed that morphine had analgesic action during medication(P < 0.05).But the paw withdrawal threshold measured at I7,I9 was significantly lower than that at I1(P < 0.05).In bone cancer model rats,rats in group BM had lower paw withdrawal threshold compared to that in group BN at I9(P < 0.05).In SNI model,the paw withdrawal threshold in group SM and group SD was significantly lower than that in group SN at I7 and I9(P < 0.05).Conclusion: Intrathecally-administered specific δ-opioid receptor antagonist(naltrindole),can restrain morphine tolerance.These results suggest that δ-opioid receptor may be involved in the formation of morphine tolerance.

Inhibition of Histone Deacetylases Attenuates Morphine Tolerance and Restores MOR Expression in the DRG of BCP Rats

Increased Methylation of the MOR Gene Proximal Promoter in Primary Sensory Neurons Plays a Crucial Role in the Decreased Analgesic Effect of Opioids in Neuropathic Pain

HDAC inhibitor TSA ameliorates mechanical hypersensitivity and potentiates analgesic effect of morphine in a rat model of bone cancer pain by restoring μ-opioid receptor in spinal cord

Overexpression of GDNF in Spinal Cord Attenuates Morphine Analgesic Tolerance in Rats with Bone Cancer Pain

Suppression of histone deacetylases by SAHA relieves bone cancer pain in rats via inhibiting activation of glial cells in spinal dorsal horn and dorsal root ganglia

Suppressing HMGB1-TLR4-Mediated Neuroinflammation Alleviates Morphine Tolerance via Inhibiting AMPK-HO-1 Pathway in The Spinal Cord of Mice

Blockade of Neuronal Dopamine D2 Receptor Attenuates Morphine Tolerance in Mice Spinal Cord

Suppressing High Mobility Group Box-1 Release Alleviates Morphine Tolerance Via the Adenosine 5'-Monophosphate-activated Protein Kinase/heme Oxygenase-1 Pathway.

Inhibition of Morphine Tolerance by MrgC Receptor Via Modulation of Interleukin-1Β and Matrix Metalloproteinase 9 in Dorsal Root Ganglia in Rats.

Involvement of Chemokine Cxcl11 in the Development of Morphine Tolerance in Rats with Cancer-Induced Bone Pain

Suppression of HDAC2 in Spinal Cord Alleviates Mechanical Hyperalgesia and Restores KCC2 Expression in a Rat Model of Bone Cancer Pain.

Effects of dezocine on morphine tolerance and opioid receptor expression in a rat model of bone cancer pain

Histone Deacetylase Inhibitor-Induced Emergence of Synaptic Δ-Opioid Receptors and Behavioral Antinociception in Persistent Neuropathic Pain

Src Kinase Inhibition Attenuates Morphine Tolerance without Affecting Reinforcement or Psychomotor Stimulation

Effect of the histone deacetylase inhibitors on behavioural sensitization to a single morphine exposure in mice.

Upregulation of (C-X-C motif) Ligand 13 (CXCL13) Attenuates Morphine Analgesia in Rats with Cancer-Induced Bone Pain

Interactions of the potent D-amino acid oxidase inhibitor CBIO with morphine in pain and tolerance to analgesia.

Disruption of Cdk5-Associated Phosphorylation of Residue Threonine-161 of the Delta-Opioid Receptor: Impaired Receptor Function and Attenuated Morphine Antinociceptive Tolerance

Effect of intrathecal δ-opioid receptor antagonists specificity on morphine tolerance in rats with chronic pain

Autophagy in Superficial Spinal Dorsal Horn Accelerates the Cathepsin B-dependent Morphine Antinociceptive Tolerance.

Small G-Protein Rheb Gates Mammalian Target of Rapamycin Signaling to Regulate Morphine Tolerance in Mice.